OW 2025 4 - 7 November 2025

STEP UP: Final dose responder analysis in participants randomized to semaglutide 7.2 mg

Authors :

W. Timothy Garvey¹; Jøran Hjelmesæth²; Kristoffer Jensen Kolnes³; Shilpa M⁴; Niklas Kahr Rasmussen³; Julio Rosenstock⁵; Ildiko Lingvay⁶

Affiliations

View Details Hide Details

{{ getPageNum(PDFPage) }}

Download poster (.pdf)

Download infographic (.pdf)

Keywords

Obesity

Congress poster

GLP-1 RA

Semaglutide

PHASE 3 (RCT)